Bird & Bird has advised lead investor Forbion on the deal. Forbion completed the £35 million (c.$43 million) Series A financing in LoQus23 Therapeutics, to advance...
You must be a Standard 1 Year member to access this content.
Goodwin advised OKRA.ai on the deal. Bird & Bird and Ropes & Gray advised Envision Pharma Group. OKRA.ai announced their acquisition by Envision Pharma Group (Envision). Envision...
You must be a Standard 1 Year member to access this content.
White & Case LLP has advised Carlyle as lead investor on the Series B investment round in Hack The Box, advised by Marriott Harrison. Bird &...
You must be a Standard 1 Year member to access this content.
Bird & Bird has advised the Dementia Discovery Fund on the deal. The investment will enable Amphista to accelerate the application of its technology into indications...
You must be a Standard 1 Year member to access this content.
Bird & Bird advised Urban-Air Port Ltd on the deal. Urban-Air Port Ltd (UAP) received a landmark investment from Supernal, previously the Urban Air Mobility Division...
You must be a Standard 1 Year member to access this content.
Ashfords advised life sciences company Iksuda Therapeutics on the deal. Bird & Bird advised Mirae Asset Capital, Celltrion and Premier Partners. Iksuda is the developer of...
You must be a Standard 1 Year member to access this content.
Ashfords advised life sciences company Iksuda Therapeutics on the deal. Bird & Bird advised Mirae Asset Capital, Celltrion and Premier Partners. Iksuda is the developer of...
You must be a Standard 1 Year member to access this content.
